Colorectal Cancer Trial, Recruiting NCT06746012 Sponsor: Ohio State University Comprehensive Cancer Center Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06746012
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • Adults aged 18 or older
  • People who have been diagnosed with stage I, II, or III colon or rectal cancer
  • People who have had surgery aimed at fully removing the cancer (people with rectal cancer who were managed without surgery may also be eligible)
  • People who finished all cancer treatment — such as chemotherapy, radiation, or surgery — at least six months before joining the trial
  • People who own a smartphone with internet access and can receive text messages
  • People who can speak, read, and understand English
  • People who are able to do physical activity on their own, based on a standard readiness questionnaire (PAR-Q), and who have doctor clearance if the questionnaire indicates that is needed
  • People whose general physical functioning falls within a certain range, as assessed through their medical records (confirm with trial site)
  • People who have a family member or caregiver who is willing to support them and take part in the study
  • People who are able to give informed consent to participate

For family caregivers:

  • Any adult who lives in the same household as the patient
  • People willing to take part in all parts of the program and any required assessments
  • People who also meet several of the patient criteria above — specifically, being 18 or older, owning a smartphone with internet access, being able to speak/read/understand English, and being able to give informed consent

For healthcare professionals (called SMEs in the trial):

  • Medical, radiation, or surgical oncologists; advanced practice providers; registered nurses; dietitians; exercise physiologists; physical therapists; patient navigators; patient advocates or champions; or social workers — all with at least 12 months of experience working with colorectal cancer survivors

Who may not be able to join:

For patients:

  • People whose responses to the physical activity readiness questionnaire (PAR-Q) suggest exercise may not be safe for them, and for whom doctor clearance cannot be obtained
  • People who have a major surgery planned during the study period
  • People who are scheduled to receive any cancer treatment during the study
  • People currently being actively treated for another cancer (exceptions may apply for certain non-melanoma skin cancers, early-stage cervical cancer, or prostate cancer being managed with monitoring only)
  • People with a self-reported history of serious heart, lung, bone, muscle, or joint conditions that would prevent moderate physical activity
  • People with a self-reported history of psychiatric conditions that would prevent participation in the program or giving informed consent
  • People currently taking part in another clinical trial focused on weight loss, physical activity, or diet
  • People who are currently pregnant or planning to become pregnant during the study period
  • People who will be living outside the United States during the study period
  • People who are currently incarcerated

For family caregivers:

  • The same exclusion criteria as listed above for patients apply to family caregivers as well

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roberto M Benzo, PhD, Ohio State University Comprehensive Cancer Center

Phone: 800-293-5066

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
3 May 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Perceived usability (Phase II); End user's perception of the quality of the mHealth application (Phase II); User acceptance of mHealth services (Phase II); Usability (Phase III); Acceptability of the program (Phase III); End user's perception of the quality of the mHealth application (Phase III); Recruitment rate (Phase III); Adherence rate (Phase III); Retention rate (Phase III); Acceptability of the measurement rate (Phase III)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov